[HTML][HTML] An overview of the common methods used to measure treatment adherence

LA Anghel, AM Farcas, RN Oprean - Medicine and pharmacy …, 2019 - ncbi.nlm.nih.gov
Methods This overview is based on an online search of PubMed database and includes the
relevant articles in this field. Results We included both direct and indirect methods for …

Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology

JCA Broen, JM van Laar - Nature Reviews Rheumatology, 2020 - nature.com
The introduction of biologic DMARDs into rheumatology has resulted in a substantial
reduction of the burden of many rheumatic diseases. In the slipstream of the success …

Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic

C Kavadichanda, S Shah, A Daber, D Bairwa… - …, 2021 - academic.oup.com
Objectives To assess acceptability of teleconsultation among the socioeconomically
marginalized sections of patients with rheumatic and musculoskeletal diseases (RMDs), to …

Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study

A Balsa, MJG de Yébenes, L Carmona - Annals of the rheumatic …, 2022 - ard.bmj.com
Non-adherence challenges efficacy and costs of healthcare. Knowledge of the underlying
factors is essential to design effective intervention strategies. Objectives To estimate the …

Medication non-adherence in rheumatology, oncology and cardiology: a review of the literature of risk factors and potential interventions

VF Gil-Guillen, A Balsa, B Bernárdez… - International Journal of …, 2022 - mdpi.com
Medication adherence is directly associated with health outcomes. Adherence has been
reviewed extensively; however, most studies provide a narrow scope of the problem …

Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis

E Neter, L Glass-Marmor, A Wolkowitz, I Lavi, A Miller - BMC neurology, 2021 - Springer
Background Though adherence to disease-modifying therapies (DMTs) among persons with
multiple sclerosis (PwMS) varies and is often below 80%, only few prospective studies on …

Real-world evidence for adherence and persistence with atorvastatin therapy

K Tsioufis, JM Castellano Vázquez, G Sykara… - Cardiology and …, 2021 - Springer
Atorvastatin, which has been approved by regulatory agencies for primary-and secondary-
prevention patients with dyslipidemia, has historically been the most commonly prescribed …

Annual direct cost and cost-drivers of systemic lupus erythematosus: a multi-center cross-sectional study from cstar registry

H Wang, M Li, K Zou, Y Wang, Q Jia, L Wang… - International Journal of …, 2023 - mdpi.com
Background: To estimate the annual direct costs and cost-drivers associated with systemic
lupus erythematosus (SLE) patients in China. Methods: A multi-center, cross-sectional study …

Treating rheumatoid arthritis

I Korol, RH Baumeister - JAAPA, 2023 - journals.lww.com
Rheumatoid arthritis (RA) affects about 1% of the world's population and can lead to loss of
joint function, reduced mobility, and permanent damage to cartilage and bone. Treatment …

Serial mediation of illness perception and beliefs about medicines in the relationship between patient satisfaction and medication adherence: An evaluation of self …

E Temeloglu Sen, HO Sertel Berk… - Journal of Health …, 2023 - journals.sagepub.com
This study examined the effect of patient satisfaction on medication adherence through
serial mediation of Self Regulatory Model (SRM) components which are illness perception …